Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Associated Coagulopathy (CAC) in Septic Critically Ill Patients- a Retrospective Cohort Study

NCT05496816 is registered in ClinicalTrials.gov with Cantonal Hospital Zenica as lead sponsor.

NCT NCT05496816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05496816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Associated Coagulopathy (CAC) in Septic Critically Ill Patients- a Retrospective Cohort Study
Lead sponsor
Cantonal Hospital Zenica
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
December 31, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coagulation disorder, covid 19 associated coagulopathy, sepsis, septic shock